Literature DB >> 30042193

Interactions between Macrophages and Cyst-Lining Epithelial Cells Promote Kidney Cyst Growth in Pkd1-Deficient Mice.

Yang Yang1,2, Meihan Chen1, Jie Zhou1, Jiayi Lv1, Shuwei Song1, LiLi Fu1, Jiejian Chen1,3, Ming Yang1, Changlin Mei4.   

Abstract

BACKGROUND: Autosomal-dominant polycystic kidney disease (ADPKD) is the leading inherited renal disease worldwide. The proproliferative function of macrophages is associated with late-stage cyst enlargement in mice with PKD; however, the way in which macrophages act on cyst-lining epithelial cells (CLECs) has not been well elucidated.
METHODS: We generated a rapid-onset PKD mouse model by inactivating Pkd1 on postnatal day 10 (P10) and compared cell proliferation and differential gene expression in kidney tissues of the PKD mice and wild-type (WT) littermates.
RESULTS: The cystic phenotype was dominant from P18. A distinct peak in cell proliferation in polycystic kidneys during P22-P30 was closely related to late-stage cyst growth. Comparisons of gene expression profiles in kidney tissues at P22 and P30 in PKD and WT mice revealed that arginine metabolism was significantly activated; 204 differentially expressed genes (DEGs), including Arg1, an arginine metabolism-associated gene, were identified in late-stage polycystic kidneys. The Arg1-encoded protein, arginase-1 (ARG1), was predominantly expressed in macrophages in a time-dependent manner. Multiple-stage macrophage depletion verified that macrophages expressing high ARG1 levels accounted for late-stage cyst enlargement, and inhibiting ARG1 activity significantly retarded cyst growth and effectively lowered the proliferative indices in polycystic kidneys. In vitro experiments revealed that macrophages stimulated CLEC proliferation, and that L-lactic acid, primarily generated by CLECs, significantly upregulated ARG1 expression and increased polyamine synthesis in macrophages.
CONCLUSIONS: Interactions between macrophages and CLECs promote cyst growth. ARG1 is a key molecule involved in this process and is a potential therapeutic target to help delay ADPKD progression.
Copyright © 2018 by the American Society of Nephrology.

Entities:  

Keywords:  arginine; macrophage; metabolism; polycystic kidney disease; proliferation

Mesh:

Substances:

Year:  2018        PMID: 30042193      PMCID: PMC6115670          DOI: 10.1681/ASN.2018010074

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  55 in total

1.  Scattered Deletion of PKD1 in Kidneys Causes a Cystic Snowball Effect and Recapitulates Polycystic Kidney Disease.

Authors:  Wouter N Leonhard; Malu Zandbergen; Kimberley Veraar; Susan van den Berg; Louise van der Weerd; Martijn Breuning; Emile de Heer; Dorien J M Peters
Journal:  J Am Soc Nephrol       Date:  2014-10-31       Impact factor: 10.121

2.  Distinct macrophage phenotypes contribute to kidney injury and repair.

Authors:  Sik Lee; Sarah Huen; Hitoshi Nishio; Saori Nishio; Heung Kyu Lee; Bum-Soon Choi; Christiana Ruhrberg; Lloyd G Cantley
Journal:  J Am Soc Nephrol       Date:  2011-02       Impact factor: 10.121

3.  Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation.

Authors:  Juan-Carlos Rodríguez-Prados; Paqui G Través; Jimena Cuenca; Daniel Rico; Julián Aragonés; Paloma Martín-Sanz; Marta Cascante; Lisardo Boscá
Journal:  J Immunol       Date:  2010-05-24       Impact factor: 5.422

4.  Overexpression of innate immune response genes in a model of recessive polycystic kidney disease.

Authors:  M Mrug; J Zhou; Y Woo; X Cui; A J Szalai; J Novak; G A Churchill; L M Guay-Woodford
Journal:  Kidney Int       Date:  2007-10-24       Impact factor: 10.612

5.  A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1.

Authors:  Klaus Piontek; Luis F Menezes; Miguel A Garcia-Gonzalez; David L Huso; Gregory G Germino
Journal:  Nat Med       Date:  2007-10-28       Impact factor: 53.440

6.  Pkd2 dosage influences cellular repair responses following ischemia-reperfusion injury.

Authors:  Sony Prasad; John Patrick McDaid; Frederick Wai Keung Tam; John Lionel Haylor; Albert Chee Meng Ong
Journal:  Am J Pathol       Date:  2009-09-03       Impact factor: 4.307

7.  M2-like macrophage polarization in high lactic acid-producing head and neck cancer.

Authors:  Toshimitsu Ohashi; Mitsuhiro Aoki; Hiroyuki Tomita; Takashi Akazawa; Katsuya Sato; Bunya Kuze; Keisuke Mizuta; Akira Hara; Hitoshi Nagaoka; Norimitsu Inoue; Yatsuji Ito
Journal:  Cancer Sci       Date:  2017-05-19       Impact factor: 6.716

Review 8.  Role of Polyamines in Immune Cell Functions.

Authors:  Rebecca S Hesterberg; John L Cleveland; Pearlie K Epling-Burnette
Journal:  Med Sci (Basel)       Date:  2018-03-08

9.  Effect of arginase inhibition on ischemia-reperfusion injury in patients with coronary artery disease with and without diabetes mellitus.

Authors:  Oskar Kövamees; Alexey Shemyakin; John Pernow
Journal:  PLoS One       Date:  2014-07-29       Impact factor: 3.240

10.  Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy.

Authors:  Isaline Rowe; Marco Chiaravalli; Valeria Mannella; Valeria Ulisse; Giacomo Quilici; Monika Pema; Xuewen W Song; Hangxue Xu; Silvia Mari; Feng Qian; York Pei; Giovanna Musco; Alessandra Boletta
Journal:  Nat Med       Date:  2013-03-24       Impact factor: 53.440

View more
  21 in total

Review 1.  STAT signaling in polycystic kidney disease.

Authors:  Sebastian Strubl; Jacob A Torres; Alison K Spindt; Hannah Pellegrini; Max C Liebau; Thomas Weimbs
Journal:  Cell Signal       Date:  2020-04-20       Impact factor: 4.315

Review 2.  Role of chemokines, innate and adaptive immunity.

Authors:  Kurt A Zimmerman; Katharina Hopp; Michal Mrug
Journal:  Cell Signal       Date:  2020-04-20       Impact factor: 4.315

3.  Interleukin-1 receptor activation aggravates autosomal dominant polycystic kidney disease by modulating regulated necrosis.

Authors:  Bo Yang; Lili Fu; Jamie R Privratsky; Xiaohan Lu; Jiafa Ren; Changlin Mei; Steven D Crowley
Journal:  Am J Physiol Renal Physiol       Date:  2019-05-29

Review 4.  The Controversial Role of Fibrosis in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Maria Fragiadaki; Fiona M Macleod; Albert C M Ong
Journal:  Int J Mol Sci       Date:  2020-11-25       Impact factor: 5.923

5.  Nuclear Condensation of CDYL Links Histone Crotonylation and Cystogenesis in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Lin Dang; Xinyi Cao; Tianye Zhang; Yongzhan Sun; Shanshan Tian; Tianyu Gong; Hui Xiong; Peipei Cao; Yuhao Li; Shengqiang Yu; Li Yang; Lirong Zhang; Tong Liu; Kai Zhang; Jing Liang; Yupeng Chen
Journal:  J Am Soc Nephrol       Date:  2022-08-02       Impact factor: 14.978

6.  Inhibiting Focal Adhesion Kinase Ameliorates Cyst Development in Polycystin-1-Deficient Polycystic Kidney Disease in Animal Model.

Authors:  Jinzhao He; Shun Zhang; Zhiwei Qiu; Xiaowei Li; Huihui Huang; William Jin; Yue Xu; Guangying Shao; Liang Wang; Jia Meng; Shuyuan Wang; Xiaoqiang Geng; Yingli Jia; Min Li; Baoxue Yang; Hua A Jenny Lu; Hong Zhou
Journal:  J Am Soc Nephrol       Date:  2021-09       Impact factor: 14.978

7.  Super-enhancer-driven metabolic reprogramming promotes cystogenesis in autosomal dominant polycystic kidney disease.

Authors:  Zeyun Mi; Yandong Song; Xinyi Cao; Yi Lu; Zhiheng Liu; Xu Zhu; Meijuan Geng; Yongzhan Sun; Bingxue Lan; Chaoran He; Hui Xiong; Lirong Zhang; Yupeng Chen
Journal:  Nat Metab       Date:  2020-07-13

8.  Tubular STAT3 Limits Renal Inflammation in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Amandine Viau; Maroua Baaziz; Amandine Aka; Manal Mazloum; Clément Nguyen; E Wolfgang Kuehn; Fabiola Terzi; Frank Bienaimé
Journal:  J Am Soc Nephrol       Date:  2020-04-01       Impact factor: 10.121

9.  Interstitial microRNA miR-214 attenuates inflammation and polycystic kidney disease progression.

Authors:  Ronak Lakhia; Matanel Yheskel; Andrea Flaten; Harini Ramalingam; Karam Aboudehen; Silvia Ferrè; Laurence Biggers; Abheepsa Mishra; Christopher Chaney; Darren P Wallace; Thomas Carroll; Peter Igarashi; Vishal Patel
Journal:  JCI Insight       Date:  2020-04-09

10.  TWEAK Signaling Pathway Blockade Slows Cyst Growth and Disease Progression in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Adrian Cordido; Laura Nuñez-Gonzalez; Julio M Martinez-Moreno; Olaya Lamas-Gonzalez; Laura Rodriguez-Osorio; Maria Vanessa Perez-Gomez; Diego Martin-Sanchez; Patricia Outeda; Marco Chiaravalli; Terry Watnick; Alessandra Boletta; Candido Diaz; Angel Carracedo; Ana B Sanz; Alberto Ortiz; Miguel A Garcia-Gonzalez
Journal:  J Am Soc Nephrol       Date:  2021-06-21       Impact factor: 14.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.